Literature DB >> 19959779

Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003.

Isabelle Deltour1, Christoffer Johansen, Anssi Auvinen, Maria Feychting, Lars Klaeboe, Joachim Schüz.   

Abstract

In Denmark, Finland, Norway, and Sweden, the use of mobile phones increased sharply in the mid-1990s; thus, time trends in brain tumor incidence after 1998 may provide information about possible tumor risks associated with mobile phone use. We investigated time trends in the incidence of glioma and meningioma in Denmark, Finland, Norway, and Sweden from 1974 to 2003, using data from national cancer registries. We used joinpoint regression models to analyze the annual incidence rates of glioma and meningioma. During this period, 59,984 men and women aged 20-79 years were diagnosed with brain tumors in a population of 16 million adults. All statistical tests were two-sided. From 1974 to 2003, the incidence rate of glioma increased by 0.5% per year (95% confidence interval [CI] = 0.2% to 0.8%) among men and by 0.2% per year (95% CI = -0.1% to 0.5%) among women and that of meningioma increased by 0.8% per year (95% CI = 0.4% to 1.3%) among men, and after the early 1990s, by 3.8% per year (95% CI = 3.2% to 4.4%) among women. No change in incidence trends were observed from 1998 to 2003, the time when possible associations between mobile phone use and cancer risk would be informative about an induction period of 5-10 years.

Entities:  

Mesh:

Year:  2009        PMID: 19959779     DOI: 10.1093/jnci/djp415

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  38 in total

1.  The potential risk factors for atypical and anaplastic meningiomas: clinical series of 1,239 cases.

Authors:  Ruo-Fei Liang; Ying-Jie Xiu; Xiang Wang; Mao Li; Yuan Yang; Qing Mao; Yan-Hui Liu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.

Authors:  Varun R Kshettry; Quinn T Ostrom; Carol Kruchko; Ossama Al-Mefty; Gene H Barnett; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2015-05-24       Impact factor: 12.300

3.  Hormonal contraceptive use and risk of glioma among younger women: a nationwide case-control study.

Authors:  Lene Andersen; Søren Friis; Jesper Hallas; Pernille Ravn; Bjarne W Kristensen; David Gaist
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

4.  Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007.

Authors:  I Baldi; A Gruber; A Alioum; E Berteaud; P Lebailly; A Huchet; T Tourdias; G Kantor; J P Maire; A Vital; H Loiseau
Journal:  Neuro Oncol       Date:  2011-10-06       Impact factor: 12.300

5.  Epidemiology for primary brain tumors: a nationwide population-based study.

Authors:  Amélie Darlix; Sonia Zouaoui; Valérie Rigau; Faiza Bessaoud; Dominique Figarella-Branger; Hélène Mathieu-Daudé; Brigitte Trétarre; Fabienne Bauchet; Hugues Duffau; Luc Taillandier; Luc Bauchet
Journal:  J Neurooncol       Date:  2016-11-16       Impact factor: 4.130

6.  Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry.

Authors:  Birthe Krogh Rasmussen; Steinbjørn Hansen; René J Laursen; Michael Kosteljanetz; Henrik Schultz; Bente Mertz Nørgård; Rikke Guldberg; Kim Oren Gradel
Journal:  J Neurooncol       Date:  2017-08-31       Impact factor: 4.130

7.  Cancers of the brain and CNS: global patterns and trends in incidence.

Authors:  Adalberto Miranda-Filho; Marion Piñeros; Isabelle Soerjomataram; Isabelle Deltour; Freddie Bray
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300

8.  Working memory and the identification of facial expression in patients with left frontal glioma.

Authors:  Yong-Gao Mu; Ling-Juan Huang; Shi-Yun Li; Chao Ke; Yu Chen; Yu Jin; Zhong-Ping Chen
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

9.  Growth Inhibition and Induction of Apoptosis in SHG-44 Glioma Cells by Chinese Medicine Formula "Pingliu Keli".

Authors:  Peng Cao; Xueting Cai; Wuguang Lu; Fei Zhou; Jiege Huo
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-08       Impact factor: 2.629

Review 10.  Brain tumor stem cells as therapeutic targets in models of glioma.

Authors:  Dan Richard Laks; Koppany Visnyei; Harley Ian Kornblum
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.